We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Postoperative Pain

News List

FDA Grants Priority Review Designation for HTX-011 americanpharmaceuticalreview
January 03, 2019
Heron Therapeutics announced the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for Heron's investigational agent, HTX-011, and has granted it a Priority Review designation.....
Ultrarestrictive Opioid Rx Protocol Cuts Postoperative Opioid Use drugs
December 10, 2018
An ultrarestrictive opioid prescription protocol (UROPP) can reduce the number of opioids prescribed to patients after gynecologic and abdominal surgery....
HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA americanpharmaceuticalreview
June 27, 2018
Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs